"Ai & biotech" on Cryptosearcher: the stories, the context, and what they actually mean.
Roche and Recursion Pharmaceuticals announced their first AI-discovered drug target for a neurodegenerative disease, validating a five-year, $12 billion partnership that processes millions of cellular images to find treatment patterns humans miss.
August 5, 2026
